Effect of Cognitive Behavioural Therapy in Improving Sleep and Health Status in Patients with Cardiometabolic Syndrome: a Meta-Analysis
-
Published:2023-11-23
Issue:
Volume:
Page:
-
ISSN:1937-1217
-
Container-title:International Journal of Cognitive Therapy
-
language:en
-
Short-container-title:J Cogn Ther
Author:
Xu Dawei, Cardell Elizabeth, Xu Miao, Ji Yunxin, Lou Zhongze, Sun JingORCID, Li Li
Abstract
AbstractThe aim of this study was to assess the effect of cognitive behavioural therapy intervention on sleep and health improvement in patients with cardiometabolic syndrome and sleep problems. This study also aimed to assess the effect of different study designs to explain the overall intervention effect through subgroup analysis. Relevant randomized controlled trial studies were searched through six online databases. The PEDro scale was used to assess the quality of the included studies. The random effects model was used to assess the mean difference, effect size, and standard deviation of the outcome variables. The heterogeneity of the included studies was assessed using I2 and Q tests. Publication bias was assessed by the Egger test. Cognitive behavioural therapy intervention provided a significant effect in improving the Pittsburgh Sleep Quality Index, Insomnia Severity Index, total sleep time, sleep efficiency, depression, fatigue, and HbA1c. The effect of cognitive behavioural therapy is more significant when relaxation training and education components are included. Cognitive behavioural therapy is suitable for the treatment of sleep problems in patients with cardiometabolic syndrome. Cognitive behavioural therapy is also effective on depression and fatigue but has a limited effect on blood pressure and biomedical indicators related to cardiometabolic syndrome.
Funder
Griffith University
Publisher
Springer Science and Business Media LLC
Subject
Experimental and Cognitive Psychology
Reference88 articles.
1. Ahmad, M. I., & Shapiro, M. D. (2021). Preventing diabetes and atherosclerosis in the cardiometabolic syndrome. Current Atherosclerosis Reports, 23(4), 16. https://doi.org/10.1007/s11883-021-00913-8 2. *Alshehri, M. M., Alenazi, A. M., Alothman, S. A., Rucker, J. L., Phadnis, M. A., Miles, J. M., … Kluding, P. M. (2021). Using cognitive behavioral therapy for insomnia in people with type 2 diabetes, pilot RCT part I: Sleep and concomitant symptom. Behavioral Sleep Medicine, 19(5), 652–671. https://doi.org/10.1080/15402002.2020.1831501 3. *Alshehri, M. M., Alothman, S. A., Alenazi, A. M., Rucker, J. L., Phadnis, M. A., Miles, J. M., … Kluding, P. M. (2020). The effects of cognitive behavioral therapy for insomnia in people with type 2 diabetes mellitus, pilot RCT part II: Diabetes health outcomes. BMC Endocrine Disorders, 20(1), 136. https://doi.org/10.1186/s12902-020-00612-6 4. Baillargeon, L., Demers, M., & Ladouceur, R. (1998). Stimulus-control: Nonpharmacologic treatment for insomnia. Canadian Family Physician, 44, 73–79. 5. Bathgate, C. J., & Fernandez-Mendoza, J. (2018). Insomnia, short sleep duration, and high blood pressure: Recent evidence and future directions for the prevention and management of hypertension. Current Hypertension Reports, 20(6), 52. https://doi.org/10.1007/s11906-018-0850-6
|
|